QEFA - ETF AI Analysis
Top Page
SPDR MSCI EAFE StrategicFactors ETF (QEFA)
Rating:65Neutral
Price Target:―
Positive Factors
Strong Overall Recent Performance
The ETF has shown solid gains so far this year and in recent months, indicating positive momentum.
Leading Holding With Very Strong Returns
The largest position, ASML Holding, has delivered very strong performance, giving the fund a powerful growth driver.
Broad International Diversification
The fund spreads its investments across many countries and sectors outside the U.S., helping reduce the impact of problems in any single market or industry.
Negative Factors
Mixed Results Among Top Holdings
Several major positions, such as AstraZeneca and Unilever, have been weak or slightly negative this year, which can drag on overall returns.
Moderate Expense Ratio
The fund’s fees are not extremely high but are also not among the very lowest, meaning costs still slightly reduce investor returns over time.
Heavy Exposure to Developed Foreign Markets
With most assets in regions like Japan, the UK, and Europe and only a small slice in the U.S., the ETF is sensitive to economic and currency swings in those foreign markets.
QEFA vs. SPDR S&P 500 ETF (SPY)
AUM1.02B
RegionDeveloped Markets
Expense Ratio0.30%
Beta0.56
IssuerState Street
Inception DateJun 04, 2014
Dividend Yield2.76%
Asset ClassEquity
Index TrackedMSCI EAFE Factor Mix A-Series (USD)
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume64,800
30 Day Avg. Volume33,138
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
113.59Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering618
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
QEFA Summary
QEFA is an ETF that follows the MSCI EAFE Factor Mix A-Series Index, giving you broad exposure to developed markets outside North America, such as Europe and Japan. It holds many types of companies and sectors, including well-known names like Nestlé and Unilever, and uses a mix of strategies that aim to focus on steadier, higher-quality stocks. Someone might invest in QEFA to diversify beyond the U.S. and add international growth potential in one simple fund. A key risk is that international stock prices can go up and down with global markets and currency swings.
How much will it cost me?The SPDR MSCI EAFE StrategicFactors ETF (Ticker: QEFA) has an expense ratio of 0.3%, meaning you’ll pay $3 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed to incorporate multiple investment factors like value, low volatility, and quality into its strategy.
What would affect this ETF?The QEFA ETF, which focuses on developed markets outside North America, could benefit from stable economic growth in Europe and Asia, as well as increased demand for high-quality and low-volatility stocks in sectors like healthcare and consumer defensive. However, it may face challenges from rising interest rates, which could pressure financial and real estate sectors, and geopolitical tensions or regulatory changes in its key regions could negatively impact its top holdings and overall performance.
QEFA Top 10 Holdings
QEFA’s story starts with ASML, whose rising year-to-date run has been a key engine for returns, even as its shorter-term moves look a bit choppy. Health care giants Novartis and Roche are more steady players, offering stability but not much recent spark, while AstraZeneca has been losing steam and weighing on the fund. Consumer staples like Nestlé and Unilever have shown mixed, slightly lagging momentum, softening the defensive ballast. Overall, the ETF leans into developed markets outside North America, with a balanced mix across European blue chips rather than a single sector or country bet.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.15% | $21.86M | €583.75B | 67.76% | 76 Outperform | |
| Novartis AG | 1.95% | $19.84M | CHF224.54B | 20.66% | 80 Outperform | |
| Roche Holding AG | 1.93% | $19.62M | $357.63B | 26.24% | 73 Outperform | |
| AstraZeneca | 1.55% | $15.81M | $253.26B | 1.15% | 80 Outperform | |
| Nestlé SA | 1.53% | $15.61M | CHF202.92B | -8.58% | 71 Outperform | |
| Shell (UK) | 1.41% | $14.38M | £222.75B | 46.01% | 73 Outperform | |
| Unilever | 1.19% | $12.16M | £104.03B | -4.81% | 72 Outperform | |
| SAP SE | 1.18% | $11.96M | €229.94B | -13.70% | 66 Neutral | |
| Allianz | 1.03% | $10.52M | €161.40B | 19.59% | 67 Neutral | |
| BHP Group Ltd | 1.03% | $10.45M | AU$309.38B | 36.56% | 68 Neutral |
QEFA Technical Analysis
Positive
―
Price Trends
99.81
Negative
98.31
Positive
96.17
Positive
Market Momentum
-0.33
Negative
55.86
Neutral
84.31
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For QEFA, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 98.12, equal to the 50-day MA of 99.81, and equal to the 200-day MA of 96.17, indicating a neutral trend. The MACD of -0.33 indicates Negative momentum. The RSI at 55.86 is Neutral, neither overbought nor oversold. The STOCH value of 84.31 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for QEFA.
QEFA Peer Comparison
Comparison Results
Performance Comparison
QEFA
SPDR MSCI EAFE StrategicFactors ETF
99.30
13.10
15.20%
DBEF
Xtrackers MSCI EAFE Hedged Equity ETF
―
―
―
BBIN
JPMorgan BetaBuilders International Equity ETF
―
―
―
EFAV
iShares MSCI EAFE Min Vol Factor ETF
―
―
―
IHDG
WisdomTree International Hedged Quality Dividend Growth Fund
―
―
―
HFXI
IQ 50 Percent Hedged FTSE International ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents